Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,173 | -19,769 | -67,255 | -53,905 | -40,348 |
| Depreciation Amortization | 1,289 | 633 | 2,211 | 1,626 | 1,052 |
| Accounts receivable | -7,450 | -5,780 | -997 | -9,011 | -12,697 |
| Accounts payable and accrued liabilities | 6,645 | 2,752 | -4,384 | -4,736 | -2,500 |
| Other Working Capital | -15,473 | -10,577 | -26,203 | -34,930 | -32,217 |
| Other Operating Activity | 33,841 | 16,464 | 63,918 | 66,582 | 53,841 |
| Operating Cash Flow | $-27,321 | $-16,277 | $-32,710 | $-34,374 | $-32,869 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,341 | -2,110 | -39,302 | -87,913 | -99,645 |
| PPE Investments | -1,281 | -546 | -13,672 | -12,564 | -10,208 |
| Purchase Sale Intangibles | -90 | -1 | -337 | -337 | -484 |
| Other Investing Activity | -213 | -159 | -163 | -122 | -421 |
| Investing Cash Flow | $-3,835 | $-2,815 | $-53,137 | $-100,599 | $-110,275 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -19 | -9 | -91 | -82 | -66 |
| Common Stock Issued | 1,150 | 292 | 576 | 513 | 349 |
| Other Financing Activity | 0 | -1 | 0 | -1 | 1 |
| Financing Cash Flow | $1,131 | $282 | $485 | $430 | $285 |
| Exchange Rate Effect | 6,729 | 1,549 | -2,181 | 366 | -6,522 |
| Beginning Cash Position | 254,568 | 254,568 | 342,111 | 342,111 | 354,963 |
| End Cash Position | 231,271 | 237,307 | 254,568 | 207,933 | 205,583 |
| Net Cash Flow | $-23,296 | $-17,260 | $-87,543 | $-134,177 | $-149,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,321 | -16,277 | -32,710 | -34,374 | -32,869 |
| Capital Expenditure | -1,281 | -546 | -13,696 | -12,564 | -10,208 |
| Free Cash Flow | -28,602 | -16,823 | -46,406 | -46,938 | -43,077 |